← Evidence map

ArticlePloS one2026

Retraction: Combined GSTM1-Null, GSTT1-Active, GSTA1 Low-Activity and GSTP1-Variant Genotype Is Associated with Increased Risk of Clear Cell Renal Cell Carcinoma.

PLOS One EditorsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Retraction: Combined GSTM1-Null, GSTT1-Active, GSTA1 Low-Activity and GSTP1-Variant Genotype Is Associated with Increased Risk of Clear Cell Renal Cell Carcinoma. | OpenQuestion